IL17A and cancer: Induction of IL‐17‐mediated signalling, breach of epithelial barriers and activation of cancer‐associated factors provide the most convincing examples of its ability to contribute to disease (summarized in Fig. 1), though greater understanding is required to fully delineate its role in these instances, as well as others, yet unknown.